Dynavax Technologies Corp entered a new four-year Supply Agreement with West Pharmaceutical Services for syringe stoppers for its HEPLISAV-B vaccine, replacing a prior agreement, and appointed Kelly MacDonald as the principal accounting officer.
AI Assistant
DYNAVAX TECHNOLOGIES CORP
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.